226 related articles for article (PubMed ID: 36551699)
1. Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells.
Cuyàs E; Fernández-Arroyo S; Verdura S; Lupu R; Joven J; Menendez JA
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551699
[TBL] [Abstract][Full Text] [Related]
2. Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes.
Lunetti P; Di Giacomo M; Vergara D; De Domenico S; Maffia M; Zara V; Capobianco L; Ferramosca A
FEBS J; 2019 Feb; 286(4):688-709. PubMed ID: 30657636
[TBL] [Abstract][Full Text] [Related]
3. Non-tumorigenic epithelial breast cells and ionizing radiation cooperate in the enhancement of mesenchymal traits in tumorigenic breast cancer cells.
Vedoya GM; Galarza TE; Mohamad NA; Cricco GP; Martín GA
Life Sci; 2022 Oct; 307():120853. PubMed ID: 35926589
[TBL] [Abstract][Full Text] [Related]
4. EMT-Derived Alterations in Glutamine Metabolism Sensitize Mesenchymal Breast Cells to mTOR Inhibition.
Karvelsson ST; Sigurdsson A; Seip K; Grinde MT; Wang Q; Johannsson F; Mælandsmo GM; Moestue SA; Rolfsson O; Halldorsson S
Mol Cancer Res; 2021 Sep; 19(9):1546-1558. PubMed ID: 34088869
[TBL] [Abstract][Full Text] [Related]
5. Glutamine-Fructose-6-Phosphate Transaminase 2 (GFPT2) Is Upregulated in Breast Epithelial-Mesenchymal Transition and Responds to Oxidative Stress.
Wang Q; Karvelsson ST; Kotronoulas A; Gudjonsson T; Halldorsson S; Rolfsson O
Mol Cell Proteomics; 2022 Feb; 21(2):100185. PubMed ID: 34923141
[TBL] [Abstract][Full Text] [Related]
6. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
7. TGF‑β1‑induced epithelial‑mesenchymal transition increases fatty acid oxidation and OXPHOS activity via the p‑AMPK pathway in breast cancer cells.
Liu QQ; Huo HY; Ao S; Liu T; Yang L; Fei ZY; Zhang ZQ; Ding L; Cui QH; Lin J; Yu M; Xiong W
Oncol Rep; 2020 Sep; 44(3):1206-1215. PubMed ID: 32705260
[TBL] [Abstract][Full Text] [Related]
8. Integrative Transcriptomic Analysis Reveals a Multiphasic Epithelial-Mesenchymal Spectrum in Cancer and Non-tumorigenic Cells.
Panchy N; Azeredo-Tseng C; Luo M; Randall N; Hong T
Front Oncol; 2019; 9():1479. PubMed ID: 32038999
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines.
Kondaveeti Y; Guttilla Reed IK; White BA
Cancer Lett; 2015 Aug; 364(1):44-58. PubMed ID: 25917568
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program.
Aguilar E; Marin de Mas I; Zodda E; Marin S; Morrish F; Selivanov V; Meca-Cortés Ó; Delowar H; Pons M; Izquierdo I; Celià-Terrassa T; de Atauri P; Centelles JJ; Hockenbery D; Thomson TM; Cascante M
Stem Cells; 2016 May; 34(5):1163-76. PubMed ID: 27146024
[TBL] [Abstract][Full Text] [Related]
11. Snail-Overexpression Induces Epithelial-mesenchymal Transition and Metabolic Reprogramming in Human Pancreatic Ductal Adenocarcinoma and Non-tumorigenic Ductal Cells.
Liu M; Hancock SE; Sultani G; Wilkins BP; Ding E; Osborne B; Quek LE; Turner N
J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31181802
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines.
Greier MC; Runge A; Dudas J; Pider V; Skvortsova II; Savic D; Riechelmann H
Sci Rep; 2022 Aug; 12(1):13255. PubMed ID: 35918485
[TBL] [Abstract][Full Text] [Related]
13. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
14. Suppression of PGC-1α Drives Metabolic Dysfunction in TGFβ2-Induced EMT of Retinal Pigment Epithelial Cells.
Shu DY; Butcher ER; Saint-Geniez M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946753
[TBL] [Abstract][Full Text] [Related]
15. Proteomics analysis reveals the role of ubiquitin specific protease (USP47) in Epithelial to Mesenchymal Transition (EMT) induced by TGFβ2 in breast cells.
Silvestrini VC; Thomé CH; Albuquerque D; de Souza Palma C; Ferreira GA; Lanfredi GP; Masson AP; Delsin LEA; Ferreira FU; de Souza FC; de Godoy LMF; Aquino A; Carrilho E; Panepucci RA; Covas DT; Faça VM
J Proteomics; 2020 May; 219():103734. PubMed ID: 32201364
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial Dysfunction: A Novel Potential Driver of Epithelial-to-Mesenchymal Transition in Cancer.
Guerra F; Guaragnella N; Arbini AA; Bucci C; Giannattasio S; Moro L
Front Oncol; 2017; 7():295. PubMed ID: 29250487
[TBL] [Abstract][Full Text] [Related]
17. Anti-Cancer Activity of Solanum nigrum (AESN) through Suppression of Mitochondrial Function and Epithelial-Mesenchymal Transition (EMT) in Breast Cancer Cells.
Lai YJ; Tai CJ; Wang CW; Choong CY; Lee BH; Shi YC; Tai CJ
Molecules; 2016 Apr; 21(5):. PubMed ID: 27136519
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin).
Oliveras-Ferraros C; Corominas-Faja B; Cufí S; Vazquez-Martin A; Martin-Castillo B; Iglesias JM; López-Bonet E; Martin ÁG; Menendez JA
Cell Cycle; 2012 Nov; 11(21):4020-32. PubMed ID: 22992620
[TBL] [Abstract][Full Text] [Related]
19. Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition.
Halldorsson S; Rohatgi N; Magnusdottir M; Choudhary KS; Gudjonsson T; Knutsen E; Barkovskaya A; Hilmarsdottir B; Perander M; Mælandsmo GM; Gudmundsson S; Rolfsson Ó
Cancer Lett; 2017 Jun; 396():117-129. PubMed ID: 28323032
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells.
Guha M; Srinivasan S; Ruthel G; Kashina AK; Carstens RP; Mendoza A; Khanna C; Van Winkle T; Avadhani NG
Oncogene; 2014 Nov; 33(45):5238-50. PubMed ID: 24186204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
